NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis $68.02 -3.16 (-4.44%) Closing price 10/30/2026 03:59 PM EasternExtended Trading$68.04 +0.02 (+0.02%) As of 10/30/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Inspire Medical Systems Stock (NYSE:INSP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INSP alerts:Sign Up Key Stats Today's Range$67.80▼$71.2050-Day Range$60.84▼$76.8552-Week Range$38.91▼$147.03Volume796,362 shsAverage Volume753,772 shsMarket Capitalization$1.97 billionP/E Ratio30.00Dividend YieldN/APrice Target$68.82Consensus RatingHold Company Overview Inspire Medical Systems, Inc. develops and commercializes medical devices for the treatment of obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly narrows or becomes blocked during sleep. The company’s primary product is Inspire therapy, an implantable system designed to help keep the airway open by stimulating the hypoglossal nerve, which controls muscles involved in maintaining airway patency. Inspire therapy is intended for certain adults with moderate to severe OSA who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy. The system generally includes an implantable pulse generator, a breathing-sensing lead, and a stimulation lead. Patients use a handheld remote to activate the system and adjust therapy within prescribed settings. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems received U.S. regulatory approval for its upper airway stimulation system in 2014. The company markets its products primarily in the United States and also serves selected international markets, including parts of Europe and other regions where applicable regulatory approvals have been obtained.AI Generated. May Contain Errors. Read More Inspire Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreINSP MarketRank™: 2.029484348615 of 5 starsInspire Medical Systems scored higher than 41% of companies evaluated by MarketBeat, and ranked 593rd out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingInspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.10, and is based on 1 strong buy rating, 3 buy ratings, 13 hold ratings, and 3 sell ratings.Upside/DownsideThe consensus price target for Inspire Medical Systems is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageInspire Medical Systems has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inspire Medical Systems' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth24.19% Earnings GrowthEarnings for Inspire Medical Systems are expected to grow by 24.19% in the coming year, from $1.24 to $1.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is 30.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.02.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is 30.00, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.92.Price to Earnings Growth RatioInspire Medical Systems has a PEG Ratio of 5.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 2.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Inspire Medical Systems' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.89% of the float of Inspire Medical Systems has been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 4.49.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 7.07%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.57 News SentimentInspire Medical Systems has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Inspire Medical Systems this week, compared to 8 articles on an average week.Search Interest3 people have searched for INSP on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,347.00 in company stock.Percentage Held by Insiders2.20% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inspire Medical Systems' insider trading history. Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSP Stock News HeadlinesInspire Medical Systems, Inc. (INSP)October 30 at 11:16 AM | finance.yahoo.comInspire Medical Systems (INSP) Projected to Post Earnings on MondayOctober 26, 2026 | americanbankingnews.comWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.October 31 at 1:00 AM | Digest Publishing (Ad)Inspire Medical Systems, Inc. (NYSE:INSP) Stock Has Average Target Price of $68.82October 26, 2026 | americanbankingnews.comLeerink Partners Remains a Hold on Inspire Medical Systems (INSP)October 13, 2026 | theglobeandmail.comInspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100October 9, 2026 | gurufocus.comBarclays initiates coverage of Inspire Medical Systems at underweightOctober 8, 2026 | msn.comBarclays Initiates Inspire Medical Systems at Underweight With $65 Price TargetOctober 7, 2026 | marketscreener.comMSee More Headlines INSP Stock Analysis - Frequently Asked Questions How have INSP shares performed this year? Inspire Medical Systems' stock was trading at $92.20 on January 1st, 2026. Since then, INSP stock has decreased by 26.2% and is now trading at $68.02. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) issued its quarterly earnings data on Monday, August, 3rd. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of ($0.24) by $0.38. Inspire Medical Systems's revenue was down 7.6% on a year-over-year basis. Read the conference call transcript. How will Inspire Medical Systems' stock buyback program work? Inspire Medical Systems' Board of Directors authorized a stock buyback plan on Monday, August 11th 2025, which authorizes the company to repurchase $200 million in shares, according to EventVestor. This means that the company could purchase up to 8.6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its stock is undervalued. When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $101 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 6,750,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Top institutional investors of Inspire Medical Systems include Assenagon Asset Management S.A. (2.23%), Yousif Capital Management LLC (0.03%), Oregon Public Employees Retirement Fund (0.02%) and State of Alaska Department of Revenue (0.02%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, Jason P Kelly, John Rondoni, Jerry C Griffin, Randy Ban and Myriam Curet. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Tesla (TSLA), CrowdStrike (CRWD), Zscaler (ZS), Alibaba Group (BABA), Advanced Micro Devices (AMD) and Broadcom (AVGO). Company Calendar Last Earnings8/03/2026Today10/31/2026Next Earnings (Estimated)11/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 INSP's financial health is in the Green zone, according to TradeSmith. INSP has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:INSP CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,333Year Founded2007Price Target and Rating Average Price Target for Inspire Medical Systems$68.82 High Price Target$180.00 Low Price Target$39.00 Potential Upside/Downside+1.2%Consensus RatingHold Rating Score (0-4)2.10 Research Coverage20 Analysts Profitability EPS (Trailing Twelve Months)$4.62 Trailing P/E Ratio30.00 Forward P/E Ratio54.85 P/E Growth5.15Net Income$145.42 million Net Margins15.03% Pretax Margin7.72% Return on Equity8.64% Return on Assets7.45% Debt Debt-to-Equity RatioN/A Current Ratio8.55 Quick Ratio6.16 Sales & Book Value Annual Sales$911.98 million Price / Sales2.16 Cash Flow$2.86 per share Price / Cash Flow23.78 Book Value$26.88 per share Price / Book2.53Miscellaneous Outstanding Shares28,910,000Free Float28,274,000Market Cap$1.97 billion OptionableOptionable Beta0.73 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:INSP) was last updated on 10/30/2026 by MarketBeat.com Staff. From Our PartnersYour free stock pick for todayElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredCigar Lake Flooded Again Uranium Supply Shock RepeatsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | SponsoredWhat Elon Musk's Cybercab Reveal Could Mean for InvestorsJeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INSP Stock Alerts